Form D · Biotechnology
Molecular Loop Biosciences, Inc.
Newton, MA · CIK 0001775159
Offering snapshot reported Jan 25, 2022 · SEC filing
- Reported sold
- $1.79M Offering amount: $2.5M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 13, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 25, 2022 | Initial | $1,793,438 | No comparison | 14 | SEC filing |
| Apr 29, 2019 | Initial | $1,499,999 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-430667
Source: Form D, filed Jan 25, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher Mc Guiness | Director |
| Christopher Mc Guinness | Director |
| Gregory Porreca | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
90 Bridge Street
Newton, MA, 02458
Newton, MA, 02458